BMP4 aggravates mitochondrial dysfunction of HRMECs

Area of Science:

• Ophthalmology
• Cell Biology
• Biochemistry

Background:

• Mitochondrial dysfunction contributes to cell dysfunction and various retinal pathologies.
• Retinal vascular endothelial cell dysfunction is linked to inflammation, hemorrhage, and neovascularization.
• Bone morphogenetic protein 4 (BMP4) is a potential therapeutic target for retinal neovascularization, but its mechanism is unclear.

Purpose of the Study:

• To investigate the effects of BMP4 on human retinal microvascular endothelial cells (HRMECs).
• To explore BMP4's role in oxidative stress and mitochondrial function in the context of diabetic retinopathy.
• To determine if BMP4 is a viable target for treating diabetic retinopathy.

Main Methods:

• An oxidative stress model was induced in HRMECs using 4-Hydroxynonenal (4HNE).
• Cells were divided into control, 4HNE, negative control, and small interfering RNA for BMP4 (siBMP4) groups.
• Leukocyte adhesion, reactive oxygen species (ROS) levels, mitochondrial membrane potential, and oxygen consumption rate (OCR) were measured.

Main Results:

• siBMP4 treatment significantly reduced leukocyte adhesion.
• siBMP4 decreased the high ROS levels induced by 4HNE.
• BMP4 knockdown restored mitochondrial membrane potential and OCR, indicating improved mitochondrial function.

Conclusions:

• BMP4 plays a significant role in promoting leukocyte adhesion, oxidative stress, and mitochondrial dysfunction in retinal vascular endothelial cells.
• This study preliminarily confirms a link between BMP4 and retinal vascular endothelial cell dysfunction.
• Mitochondrial dysfunction and oxidative stress are likely mechanisms involved in BMP4-mediated retinal vascular endothelial cell dysfunction, suggesting BMP4 as a potential therapeutic target for diabetic retinopathy.